Study Design of a Phase III, Randomized, Placebo-Controlled Trial of Nintedanib in Children and Adolescents with Clinically Significant Fibrosing Interstitial Lung Disease (ILD)

被引：0
|
作者：
Young, L. [1 ]
Brown, K. K. [2 ]
Griese, M. [3 ]
Deutsch, G. [4 ]
Warburton, D. [5 ]
DeBoer, E. [6 ]
Cunningham, S. [7 ]
Clement, A. F. [8 ]
Schwerk, N. [9 ]
Flaherty, K. R. [10 ]
Voss, F. [11 ]
Schmid, U. [11 ]
Schlenker-Herceg, R. [12 ]
Verri, D. [13 ]
Stowasser, S. [14 ]
Clerisme-Beaty, E. M. [14 ]
Deterding, R. R. [6 ]
机构：
[1] Childrens Hosp Philadelphia, Div Pulm Med, Philadelphia, PA 19104 USA
[2] Natl Jewish Hlth, Denver, CO USA
[3] Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, Munich, Germany
[4] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[6] Univ Colorado Denver, Sect Pediat Pulm & Sleep Med, Dept Pediat, Aurora, CO USA
[7] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
[8] Sorbonne Univ, Trousseau Hosp, AP HP, Pediat Pulm Dept, Paris, France
[9] Hannover Med Sch, Clin Pediat Pulmonol Allergol & Neonatol, Hannover, Germany
[10] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[11] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[12] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[13] Boehringer Ingelheim Italia SpA, Milan, Italy
[14] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1495
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
    Michael Benatar
    Joanne Wuu
    Peter M. Andersen
    Robert C. Bucelli
    Jinsy A. Andrews
    Markus Otto
    Nita A. Farahany
    Elizabeth A. Harrington
    Weiping Chen
    Adele A. Mitchell
    Toby Ferguson
    Sheena Chew
    Liz Gedney
    Sue Oakley
    Jeong Heo
    Sowmya Chary
    Laura Fanning
    Danielle Graham
    Peng Sun
    Yingying Liu
    Janice Wong
    Stephanie Fradette
    Neurotherapeutics, 2022, 19 : 1248 - 1258
  • [42] Estimating the Effect of Nintedanib on Forced Vital Capacity in Children and Adolescents With Fibrosing Interstitial Lung Disease: Extrapolation Using a Bayesian Borrowing Approach
    Maher, T. M.
    Brown, K. K.
    Cunningham, S.
    Deboer, E. M.
    Deterding, R.
    Fiorino, E. K.
    Griese, M.
    Schwerk, N.
    Warburton, D.
    Young, L. R.
    Gahlemann, M.
    Voss, F.
    Stock, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [43] Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease
    Matthias Griese
    Matthias Kappler
    Florian Stehling
    Johannes Schulze
    Winfried Baden
    Cordula Koerner-Rettberg
    Julia Carlens
    Freerk Prenzel
    Lutz Nährlich
    Andreas Thalmeier
    Daniela Sebah
    Kai Kronfeld
    Hans Rock
    Christian Ruckes
    Martin Wetzke
    Elias Seidl
    Nicolaus Schwerk
    Orphanet Journal of Rare Diseases, 17
  • [44] Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease
    Griese, Matthias
    Kappler, Matthias
    Stehling, Florian
    Schulze, Johannes
    Baden, Winfried
    Koerner-Rettberg, Cordula
    Carlens, Julia
    Prenzel, Freerk
    Naehrlich, Lutz
    Thalmeier, Andreas
    Sebah, Daniela
    Kronfeld, Kai
    Rock, Hans
    Ruckes, Christian
    Wetzke, Martin
    Seidl, Elias
    Schwerk, Nicolaus
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [45] Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry
    Behr, Juergen
    Bonella, Francesco
    Guenther, Andreas
    Koschel, Dirk
    Prasse, Antje
    Pittrow, David
    Klotsche, Jens
    Kreuter, Michael
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [46] Randomized, placebo-controlled trial of sibutramine in the maintenance of weight loss in adolescents: A pilot study
    Berkowitz, R
    Wadden, T
    Cronquist, J
    OBESITY RESEARCH, 2003, 11 : A113 - A113
  • [47] A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy
    Fattore, Cinzia
    Boniver, Clementina
    Capovilla, Giuseppe
    Cerminara, Caterina
    Citterio, Antonietta
    Coppola, Giangennaro
    Costa, Paola
    Darra, Francesca
    Vecchi, Marilena
    Perucca, Emilio
    EPILEPSIA, 2011, 52 (04) : 802 - 809
  • [48] Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry
    Juergen Behr
    Francesco Bonella
    Andreas Günther
    Dirk Koschel
    Antje Prasse
    David Pittrow
    Jens Klotsche
    Michael Kreuter
    BMC Pulmonary Medicine, 23
  • [49] Randomized, Double Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
    Rosas, I.
    Solomon, J.
    Donoff, S.
    Woodhead, F.
    Raghu, G.
    Hilary, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] Efficacy ans safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial
    Steinfeld, J.
    Roufosse, F.
    Kahn, J. E.
    Gleich, G. J.
    Rothenberg, M. E.
    Wardlaw, A. J.
    Kirby, S. Y.
    Gilson, M.
    Bentley, J. H.
    Bradford, E. S.
    Yancey, S. W.
    PNEUMOLOGIE, 2021, 75 : S46 - S47
12345